MoneyWorks4Me

Lactose India - Quaterly Results

17 May 2022 Evaluate
The sales surged to Rs. 143.50 millions, up 42.91% for the March 2022 quarter as against Rs. 100.41 millions during the corresponding quarter previous year.The Net Profit of the company vaulted to 765.66% to Rs. 25.71  millions from Rs. 2.97 millions in the previous quarter.Operating Profit saw a handsome growth to 57.98 millions from 28.30 millions in the quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 143.50 100.41 42.91 459.39 349.63 31.39 459.39 349.63 31.39
Other Income 2.97 0.71 318.31 5.80 3.13 85.30 5.80 3.13 85.30
PBIDT 57.98 28.30 104.88 128.41 65.35 96.50 128.41 65.35 96.50
Interest 12.28 14.12 -13.03 51.16 54.48 -6.09 51.16 54.48 -6.09
PBDT 45.70 14.18 222.28 77.25 10.87 610.67 77.25 10.87 610.67
Depreciation 11.90 10.92 8.97 45.59 43.58 4.61 45.59 43.58 4.61
PBT 33.80 3.26 936.81 31.66 -32.71 -196.79 31.66 -32.71 -196.79
TAX 8.09 0.29 2689.66 7.16 -7.93 -190.29 7.16 -7.93 -190.29
Deferred Tax 2.54 -0.20 -1370.00 1.46 -8.42 -117.34 1.46 -8.42 -117.34
PAT 25.71 2.97 765.66 24.50 -24.78 -198.87 24.50 -24.78 -198.87
Equity 125.89 114.37 10.07 125.89 114.37 10.07 125.89 114.37 10.07
PBIDTM(%) 40.40 28.18 43.36 27.95 18.69 49.55 27.95 18.69 49.55
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..